Philips debuts impactful solutions in cardiology at ESC 2020 to deliver better patient care with greater efficiency
August 27 2020 - 4:00AM
Philips debuts impactful solutions in cardiology at ESC 2020 to
deliver better patient care with greater efficiency
August 27, 2020
Connected cardiology solutions help physicians elevate clinical
confidence, improve patient and staff experience, and improve
outcomes
Amsterdam, The Netherlands – Royal Philips
(NYSE: PHG, AEX: PHIA), a global leader in health technology, is
showcasing its latest cardiac care innovations at the European
Society of Cardiology ESC Congress 2020 (August 29 – September 1).
During the virtual event, Philips is presenting an integrated
portfolio of imaging, devices and informatics solutions that help
increase clinical confidence, lower the cost of care and improve
both the physician and patient experience.
“We’re connecting imaging, devices and informatics to provide
the clinical confidence that cardiologists need to deliver the
right care at the right time, for every patient,” said Bert van
Meurs, Executive Vice President and Chief Business Leader of Image
Guided Therapy at Philips. “Together, our new offerings add to a
powerful ecosystem equipped to help cardiologists realize their
vision for delivering better patient care with greater
efficiency.”
- At ESC 2020, Philips continues its leadership in interventional
echocardiography with the debut of the new Affiniti CVx
cardiovascular ultrasound solution, and the launch of Release 7.0
for EPIQ CVx that provides new ways to better appreciate
morphology, to size devices, and reduce the overall procedure
time.
- Philips interventional solutions integrate best-in-class
imaging systems, software and devices with our image-guided therapy
platform Azurion, providing seamless control from tableside and
designed to support optimal treatment in coronary interventions,
structural heart procedures, and atrial fibrillation
ablations.
- Philips cardiology informatics solutions enable delivering the
right care and access to patients’ comprehensive data whether in an
emergency situation, through the emergency care informatics suite,
or throughout the complete care pathway, with IntelliSpace
Cardiovascular. Philips emergency care informatics suite is a
pre-hospital informatics solution that provides real-time,
bidirectional feedback between emergency responders on the scene
and doctors in the hospital awaiting the arrival of the patient.
Accessible anytime and virtually anywhere, IntelliSpace
Cardiovascular supports informed decision-making by providing a
comprehensive overview of the patient’s cardiovascular care
continuum and helps save time and reduce frustration when accesing
multiple systems and advanced clinical tools.
Enabling value-based cardiac care Physicians
face an urgent task to restart elective procedures during the
COVID-19 pandamic and to get their own operations back to financial
health. With the shift to value-based care, healthcare providers
are increasingly focused on balancing the need to provide the
highest quality care with managing their operational costs. Philips
is bringing together cardiology solutions to elevate clinical
confidence, improve patient and staff experience, and improve
outcomes.
“The COVID-19 pandemic has become a catalyst for change and a
defining moment for all of us to reimagine cardiology. At Philips,
our mission to improve lives is more relevant than ever. The major
trends we already see in healthcare – innovation, digitization, the
shift from volume to value – are being accelerated by the
pandemic,” Bert van Meurs added.
The ESC Congress 2020 will be held virtually from August 29 to
September 1. Visit Philips Live! at ESC 2020 to learn more about
events that Philips is hosting at ESC, schedule a live meeting or
demonstration with a Philips team member, watch videos of cases,
and register for the Philips ESC symposium on pushing the
boundaries of cardiac visualization with an innovative echo
toolkit.
Philips is also hosting multiple webinars on cardiology topics
featuring leading worldwide experts: Management of COVID-19 related
cardiac complications – Emergency assessment of patient cardiac
condition – Early indication of patient deterioration - The role of
imaging in COVID-19: A view for the present and the future. For
more information about the symposium and other events, as well as
general information about Philips’ presence at the ESC, visit
www.philips.com/esc.
For further information, please contact:
Hans DriessenPhilips Global Press OfficeTel.: +31 6
10610417Email: hans.driessen@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people’s health and
enabling better outcomes across the health continuum from healthy
living and prevention, to diagnosis, treatment and home care.
Philips leverages advanced technology and deep clinical and
consumer insights to deliver integrated solutions. Headquartered in
the Netherlands, the company is a leader in diagnostic imaging,
image-guided therapy, patient monitoring and health informatics, as
well as in consumer health and home care. Philips generated 2019
sales of EUR 19.5 billion and employs approximately 81,000
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
- EPIQ CVxi premium interventional cardiology ultrasound
system
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Sep 2023 to Sep 2024